Search

Search Constraints

You searched for: Author/Creator Ber, Y

Search Results

1. DOP19 Urinary metabolome in newly diagnosed treatment-naïve Crohn's Disease patients: Results from the IBDomics study. (27th May 2021)

2. Long‐Term Safety ofIn UteroExposure to Anti‐TNFα Drugs for the Treatment of Inflammatory Bowel Disease: Results from the Multicenter European TEDDY Study. (March 2018)

3. P018 Proteomic profile of serum and urine in newly diagnosed patients with Inflammatory Bowel Disease: new approach for biomarker discovery. (21st January 2022)

4. P036 Analysis of intestinal tissue from newly diagnosed patients with inflammatory bowel disease reveals distinct proteomic profiles. (30th January 2023)

5. P049 Proteomic characterization of serum extracellular vesicles from newly diagnosed patients with inflammatory bowel disease. (30th January 2023)

6. P106 Identification of urine and serum diagnostic biomarkers of inflammatory bowel disease using a proteomic approach. (30th January 2023)

7. P386 Clinical presentation, management, and evolution of lymphomas in patients with Inflammatory Bowel Disease: an ENEIDA registry study. (30th January 2023)

8. P545 Safety of ustekinumab in pregnant patients with inflammatory bowel disease and in their offspring: results from the DUMBO registry of GETECCU. (21st January 2022)